Alexion Pharmaceuticals
ALXN
#620
Rank
โ‚น3.788 T
Marketcap
โ‚น17,141
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Alexion Pharmaceuticals (ALXN)

Revenue in 2021 (TTM): โ‚น462.63 Billion

According to Alexion Pharmaceuticals's latest financial reports the company's current revenue is โ‚น587.97 Billion. In 2020 the company made a revenue of โ‚น570.02 Billion an increase over the revenue in the year 2019 that were of โ‚น468.67 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alexion Pharmaceuticals from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚น462.63 B-18.84%
2020โ‚น570.02 B21.63%
2019โ‚น468.67 B20.82%
2018โ‚น387.90 B16.36%
2017โ‚น333.37 B15.17%
2016โ‚น289.46 B18.42%
2015โ‚น244.43 B16.51%
2014โ‚น209.79 B43.99%
2013โ‚น145.70 B36.79%
2012โ‚น106.51 B44.76%
2011โ‚น73.58 B44.82%
2010โ‚น50.80 B39.85%
2009โ‚น36.32 B49.29%
2008โ‚น24.33 B259.66%
2007โ‚น6.76 B4523.88%
2006โ‚น0.14 B13.14%
2005โ‚น0.12 B-70.12%
2004โ‚น0.43 B557.49%
2003โ‚น65.83 M-85.98%
2002โ‚น0.46 B-50.6%
2001โ‚น0.95 B